CRH Medical Corporation of Beneficial Interest

3.9700.00Vol 349.13K1Y Perf 89.95%
Apr 9th, 2021 16:00 DELAYED
BID3.96 ASK3.98
Open3.98 Previous Close3.97
Pre-Market- After-Market-
 - -  - -%
Target Price
4.33 
Analyst Rating
Strong Buy 1.50
Potential %
9.07 
Finscreener Ranking
★★     46.44
Insiders Trans % 3/6/12 mo.
-/-100/23 
Value Ranking
     41.31
Insiders Value % 3/6/12 mo.
-/-100/-41 
Growth Ranking
★+     38.63
Insiders Shares Cnt. % 3/6/12 mo.
-/-100/-23 
Income Ranking
 —    -
Market Cap284.33M 
Earnings Rating
Neutral
Price Range Ratio 52W %
99.14 
Earnings Date
11th May 2021

Today's Price Range

3.963.98

52W Range

1.663.99

5 Year PE Ratio Range

9.40136.20

Summary:

Buy

Technical Indicators: Neutral
Moving Averages: Strong Buy
Performance
1 Week
0.51%
1 Month
2.58%
3 Months
80.45%
6 Months
71.86%
1 Year
89.95%
3 Years
44.36%
5 Years
24.06%
10 Years
-

TickerPriceChg.Chg.%
CRHM3.970.00000.00
AAPL132.992.63002.02
GOOG2 285.8820.44000.90
MSFT255.852.60001.03
XOM55.87-0.1300-0.23
WFC40.500.47001.17
JNJ161.25-1.7200-1.06
FB312.46-0.5600-0.18
GE13.600.15001.12
JPM156.281.16000.75
Financial StrengthValueIndustryS&P 500US Markets
2.60
2.70
0.57
1.34
-15.20
Leverage Ratio 3.00
ProfitabilityValueIndustryS&P 500US Markets
1.60
-26.90
11.40
7.90
-26.35
RevenueValueIndustryS&P 500US Markets
79.30M
1.11
1.14
14.76
Earnings HistoryEstimateReportedSurprise %
Q04 20200.010.03200.00
Q03 2020-0.01-0.010.00
Q02 2020-0.08-0.0450.00
Q01 20200.00-0.03-
Q04 20190.030.02-33.33
Q03 2019-0.010.01200.00
Q02 20190.010.02100.00
Q01 20190.010.00-100.00
Earnings Per EndEstimateRevision %Trend
12/2020 QR0.010.00-
12/2020 QR0.02--
12/2021 FY0.010.00-
12/2022 FY-0.040.00-
Next Report Date11th May 2021
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume349.13K
Shares Outstanding71.62M
Trades Count770
Dollar Volume2.89M
Avg. Volume1.08M
Avg. Weekly Volume532.97K
Avg. Monthly Volume625.99K
Avg. Quarterly Volume1.16M

CRH Medical Corporation of Beneficial Interest (AMEX: CRHM) stock closed at 3.97 per share at the end of the most recent trading day (a 0% change compared to the prior day closing price) with a volume of 349.13K shares and market capitalization of 284.33M. Is a component of indices and it is traded on AMEX exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 155 people. CRH Medical Corporation of Beneficial Interest CEO is Tushar M. Ramani.

The one-year performance of CRH Medical Corporation of Beneficial Interest stock is 89.95%, while year-to-date (YTD) performance is 70.39%. CRHM stock has a five-year performance of 24.06%. Its 52-week range is between 1.66 and 3.99, which gives CRHM stock a 52-week price range ratio of 99.14%

CRH Medical Corporation of Beneficial Interest currently has a PE ratio of -11.30, a price-to-book (PB) ratio of 5.25, a price-to-sale (PS) ratio of 3.59, a price to cashflow ratio of 7.80, a PEG ratio of 2.32, a ROA of -11.86%, a ROC of -1.58% and a ROE of -35.78%. The company’s profit margin is -26.35%, its EBITDA margin is 11.40%, and its revenue ttm is $79.30 Million , which makes it $1.11 revenue per share.

Of the last four earnings reports from CRH Medical Corporation of Beneficial Interest, there were 2 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $0.00 for the next earnings report. CRH Medical Corporation of Beneficial Interest’s next earnings report date is 11th May 2021.

The consensus rating of Wall Street analysts for CRH Medical Corporation of Beneficial Interest is Strong Buy (1.5), with a target price of $4.33, which is +9.07% compared to the current price. The earnings rating for CRH Medical Corporation of Beneficial Interest stock is Neutral (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

CRH Medical Corporation of Beneficial Interest has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

CRH Medical Corporation of Beneficial Interest has a Buy technical analysis rating based on Technical Indicators (ADX : 38.26, ATR14 : 0.09, CCI20 : 4.43, Chaikin Money Flow : 0.33, MACD : 0.27, Money Flow Index : 49.11, ROC : -0.77, RSI : 77.25, STOCH (14,3) : 36.36, STOCH RSI : 0.28, UO : 59.09, Williams %R : -63.64), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of CRH Medical Corporation of Beneficial Interest in the last 12-months were: David A. Johnson (Buy at a value of $96 756), Ian Webb (Sold 25 000 shares of value $72 500 ), James Kreger (Option Excercise at a value of $0), James Kreger (Sold 14 912 shares of value $44 726 ), Richard K. Bear (Option Excercise at a value of $0), Richard K. Bear (Sold 40 000 shares of value $114 200 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
3 (75.00 %)
4 (100.00 %)
4 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
1 (25.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.50
Strong Buy
1.00
Strong Buy
1.00

CRH Medical Corporation of Beneficial Interest

CRH Medical Corp is a healthcare products and services company. The company, through its subsidiaries, provides anesthesiology services to gastroenterologists in the United States. It also specializes in the treatment of hemorrhoids utilizing its treatment protocol and patented proprietary technology. The company's product, the CRH O'Regan System, is a single-use, disposable, hemorrhoid treatment. It distributes the CRH O'Regan System, treatment protocols, operational and marketing services directly to gastroenterologists. Geographically, the company operates in the United States and Canada, of which key revenue is derived from the United States.

CEO: Tushar M. Ramani

Telephone: +1 425 658-0151

Address: 999 Canada Place, Vancouver V6C 3E1, BC, CA

Number of employees: 155

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

62%38%

Bearish Bullish

55%45%

Bearish Bullish

50%50%

News

Stocktwits